DE69419782D1 - Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung - Google Patents

Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung

Info

Publication number
DE69419782D1
DE69419782D1 DE69419782T DE69419782T DE69419782D1 DE 69419782 D1 DE69419782 D1 DE 69419782D1 DE 69419782 T DE69419782 T DE 69419782T DE 69419782 T DE69419782 T DE 69419782T DE 69419782 D1 DE69419782 D1 DE 69419782D1
Authority
DE
Germany
Prior art keywords
alpha
lactalbumin
multimeral
antibacterial composition
containing antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69419782T
Other languages
English (en)
Other versions
DE69419782T2 (de
Inventor
Sabharwal
Svanborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamlet Pharma AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69419782D1 publication Critical patent/DE69419782D1/de
Publication of DE69419782T2 publication Critical patent/DE69419782T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Electrochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
DE69419782T 1994-08-16 1994-08-16 Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung Expired - Lifetime DE69419782T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1994/000742 WO1996004929A1 (en) 1994-08-16 1994-08-16 Antibacterial composition containing multimeric alpha-lactalbumin

Publications (2)

Publication Number Publication Date
DE69419782D1 true DE69419782D1 (de) 1999-09-02
DE69419782T2 DE69419782T2 (de) 1999-12-23

Family

ID=20393168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419782T Expired - Lifetime DE69419782T2 (de) 1994-08-16 1994-08-16 Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung

Country Status (11)

Country Link
US (2) US6599874B1 (de)
EP (1) EP0776214B1 (de)
JP (1) JP3694319B2 (de)
AT (1) ATE182470T1 (de)
AU (1) AU7792294A (de)
CA (1) CA2197659C (de)
DE (1) DE69419782T2 (de)
DK (1) DK0776214T3 (de)
ES (1) ES2136206T3 (de)
GR (1) GR3031078T3 (de)
WO (1) WO1996004929A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
EP1032596B1 (de) 1997-11-21 2007-05-02 Nya Hamlet Pharma AB Herstellungsverfahren von lactalbumin
GB9724725D0 (en) * 1997-11-21 1998-01-21 Svanborg Catharina Protein production process
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
US6815419B1 (en) * 1999-07-28 2004-11-09 Morinaga Milk Industry Co., Ltd. Antiulcer agent
NZ531639A (en) * 2001-08-23 2006-02-24 Westgate Biolog Ltd Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
CN102590413B (zh) * 2012-01-18 2013-12-25 浙江省疾病预防控制中心 一种牛α-乳白蛋白的定量检测方法
HUE038910T2 (hu) 2012-08-09 2018-12-28 Hamlet Pharma Ab Profilaktikus és gyógytáp terápia
WO2024075003A1 (en) 2022-10-03 2024-04-11 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
AU542815B2 (en) 1980-05-09 1985-03-14 Leffler, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
FI892006A (fi) * 1988-04-29 1989-10-30 Phil Gold Lactalbumin saosom tillaeggsaemne i mat.
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
JP2961625B2 (ja) * 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法

Also Published As

Publication number Publication date
US20040106541A1 (en) 2004-06-03
US6599874B1 (en) 2003-07-29
US7144855B2 (en) 2006-12-05
ES2136206T3 (es) 1999-11-16
DE69419782T2 (de) 1999-12-23
DK0776214T3 (da) 1999-11-29
EP0776214A1 (de) 1997-06-04
ATE182470T1 (de) 1999-08-15
GR3031078T3 (en) 1999-12-31
JP3694319B2 (ja) 2005-09-14
EP0776214B1 (de) 1999-07-28
JPH10504547A (ja) 1998-05-06
WO1996004929A1 (en) 1996-02-22
AU7792294A (en) 1996-03-07
CA2197659A1 (en) 1996-02-22
CA2197659C (en) 2009-11-10

Similar Documents

Publication Publication Date Title
HK1014155A1 (en) Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
MY113059A (en) Controlled-release dosage forms of azithromycin
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
DE59710183D1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
DK0806941T3 (da) Liposomalt antibakterielt præparat med lav fasthed
DE69419782D1 (de) Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
IL156942A0 (en) Compounds, pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
EP1019084A4 (de) Neue antimikrobielle polypeptide und verfahren für ihre verwendung.
WO2000058475A3 (en) Streptococcus pneumoniae antigens
DE3780644D1 (de) Glykopeptid-antibiotika.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
CA2351947A1 (en) Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
CLARKE TOPICAL USE OF SILVER SULPHADIAZINE AND CHLORHEXIDINE IN THW PREVENTION OF INFECTION IN THERMAL INJURIES
ATE457730T1 (de) Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen
Ginsburg Streptococcus.
JPS57143000A (en) Antibiotic compound, manufacture and medical use
ME00858B (me) UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA
McDougall Burns and the Use of Silver Sulphadiazine 1
WO1990013660A3 (en) Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
FR2307542A1 (fr) Nouvelle preparation immunostimulante
Lechi et al. Clinical evaluation of ceftazidime in the treatment of infections caused by Pseudomonas and other gram-negative bacteria.
Tkacz et al. A comparison of mezlocillin and carbenicillin with respect to efficacy and tolerance for the treatment of bacterial infections.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SABHARWAL, HEMANT, IRVINGTON, N.Y., US SVANBORG, C

8381 Inventor (new situation)

Free format text: ERFINDER IST ANMELDER

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HAMLET PHARMA AB, LUND, SE

8381 Inventor (new situation)

Inventor name: SABHARWAL, HEMANT, IRVINGTON, N.Y., US

Inventor name: SVANBORG, CATHARINA, LUND, SE